NM_016035.5:c.202G>A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_016035.5(COQ4):c.202G>A(p.Asp68Asn) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000698 in 1,433,456 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D68H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_016035.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COQ4 | ENST00000300452.8 | c.202G>A | p.Asp68Asn | missense_variant, splice_region_variant | Exon 2 of 7 | 1 | NM_016035.5 | ENSP00000300452.3 | ||
COQ4 | ENST00000609948.1 | c.202G>A | p.Gly68Ser | missense_variant | Exon 2 of 2 | 2 | ENSP00000477292.1 | |||
COQ4 | ENST00000372875.3 | c.202G>A | p.Asp68Asn | missense_variant, splice_region_variant | Exon 2 of 4 | 2 | ENSP00000361966.3 | |||
COQ4 | ENST00000608951.5 | c.202G>A | p.Asp68Asn | missense_variant, splice_region_variant | Exon 2 of 3 | 2 | ENSP00000476323.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.98e-7 AC: 1AN: 1433456Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 712042
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.